{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:40:44Z","timestamp":1772826044775,"version":"3.50.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1097\/md.0000000000011965","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T20:45:34Z","timestamp":1535057134000},"page":"e11965","source":"Crossref","is-referenced-by-count":8,"title":["Patent foramen ovale closure or medical therapy for secondary prevention of cryptogenic stroke"],"prefix":"10.1097","volume":"97","author":[{"given":"Yingxu","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenghua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-75-20210309","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1161\/STROKEAHA.117.019141","article-title":"Statins and the risk of intracerebral hemorrhage in patients with previous ischemic stroke or transient ischemic attack","volume":"48","author":"Gaist","year":"2017","journal-title":"Stroke"},{"key":"R2-75-20210309","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/CIRCULATIONAHA.109.192272","article-title":"Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association\/American Stroke Association and the American College of Cardiology Foundation","volume":"119","author":"O\u2019Gara","year":"2009","journal-title":"Circulation"},{"key":"R3-75-20210309","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ana.410250410","article-title":"Infarcts of undetermined cause: the NINCDS Stroke Data Bank","volume":"25","author":"Sacco","year":"1989","journal-title":"Ann Neurol"},{"key":"R4-75-20210309","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0025-6196(12)60336-X","article-title":"Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts","volume":"59","author":"Hagen","year":"1984","journal-title":"Mayo Clin Proc"},{"key":"R5-75-20210309","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jacc.2006.08.063","article-title":"Patent foramen ovale and the risk of ischemic stroke in a multiethnic population","volume":"49","author":"Di Tullio","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R6-75-20210309","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/hs0302.104543","article-title":"Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA study. Atrial Septal Aneurysm","volume":"33","author":"Lamy","year":"2002","journal-title":"Stroke"},{"key":"R7-75-20210309","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.CIR.0000017498.88393.44","article-title":"Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in cryptogenic stroke study","volume":"105","author":"Homma","year":"2002","journal-title":"Circulation"},{"key":"R8-75-20210309","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1056\/NEJMoa071422","article-title":"Patent foramen ovale and cryptogenic stroke in older patients","volume":"357","author":"Handke","year":"2007","journal-title":"N Engl J Med"},{"key":"R9-75-20210309","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jacc.2005.10.044","article-title":"Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study","volume":"47","author":"Meissner","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R10-75-20210309","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jacc.2004.05.044","article-title":"Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke","volume":"44","author":"Windecker","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R11-75-20210309","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/CIRCULATIONAHA.111.030494","article-title":"Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism","volume":"125","author":"Wahl","year":"2012","journal-title":"Circulation"},{"key":"R12-75-20210309","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2012.02.021","article-title":"Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism","volume":"5","author":"Agarwal","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"R13-75-20210309","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N Engl J Med"},{"key":"R14-75-20210309","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N Engl J Med"},{"key":"R15-75-20210309","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N Engl J Med"},{"key":"R16-75-20210309","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jcin.2013.08.001","article-title":"Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis","volume":"6","author":"Khan","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"R17-75-20210309","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jacc.2015.12.023","article-title":"Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials","volume":"67","author":"Kent","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R18-75-20210309","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"R19-75-20210309","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1212\/WNL.0000000000002961","article-title":"Practice advisory: Recurrent stroke with patent foramen ovale (update of practice parameter): Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology","volume":"87","author":"Messe","year":"2016","journal-title":"Neurology"},{"key":"R20-75-20210309","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N Engl J Med"},{"key":"R21-75-20210309","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"Sondergaard","year":"2017","journal-title":"N Engl J Med"},{"key":"R22-75-20210309","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N Engl J Med"},{"key":"R23-75-20210309","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","article-title":"Cryptogenic stroke and high-risk patent foramen ovale: The DEFENSE-PFO trial","volume":"71","author":"Lee","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R24-75-20210309","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCINTERVENTIONS.112.970954","article-title":"Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials","volume":"5","author":"Pursnani","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"R25-75-20210309","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R26-75-20210309","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"R27-75-20210309","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/hrt.2010.203950","article-title":"Efficacy of percutaneous closure of patent foramen ovale: comparison among three commonly used occluders","volume":"97","author":"Thaman","year":"2011","journal-title":"Heart"},{"key":"R28-75-20210309","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2004.03.005","article-title":"Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale","volume":"101","author":"Schuchlenz","year":"2005","journal-title":"Int J Cardiol"},{"key":"R29-75-20210309","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.amjcard.2007.12.040","article-title":"Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder)","volume":"101","author":"Taaffe","year":"2008","journal-title":"Am J Cardiol"},{"key":"R30-75-20210309","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1212\/WNL.0b013e3181e0427e","article-title":"Detection of paroxysmal atrial fibrillation with transtelephonic EKG in TIA or stroke patients","volume":"74","author":"Gaillard","year":"2010","journal-title":"Neurology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000011965","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:22:37Z","timestamp":1620962557000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201808240-00075"}},"subtitle":["An update meta-analysis of randomized controlled trials"],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":30,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000011965","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}